Patricia Neuman
Medical · Salt Lake City, UTNPI 1275920597
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.6% of the total across 152 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 16.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,005 and has fallen 59.6% since, to $405 in 2025.
Across 152 payments — averaging $23.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$604
- Dexcom, Inc.$581
- AbbVie$436
- Corcept Therapeutics$404
- AstraZeneca$224
- Amgen$218
- plus $1K from 19 others
What the payments were for
- Speaking & faculty fees$1253%
- Food & beverage$3,52097%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 21 | $604 |
| Dexcom, Inc. | 7 | $581 |
| AbbVie | 24 | $436 |
| Corcept Therapeutics | 13 | $404 |
| AstraZeneca | 8 | $224 |
| Amgen(2 entities) | 12 | $218 |
| Johnson & Johnson | 10 | $162 |
| Lilly USA, LLC | 10 | $157 |
| Novartis | 6 | $113 |
| Xeris Pharmaceuticals, Inc. | 5 | $110 |
| Supernus Pharmaceuticals, Inc. | 5 | $99 |
| Boehringer Ingelheim | 5 | $98 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $93 |
| Novo Nordisk | 5 | $80 |
| Merck | 4 | $61 |
| Bayer | 2 | $35 |
| Roche Diagnostics Corporation | 2 | $29 |
| Biohaven Pharmaceuticals, Inc. | 1 | $27 |
| Phadia US Inc. | 2 | $23 |
| BD | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Therapeuticsmd, Inc. | 1 | $13 |
| Exact Sciences | 1 | $13 |
| Medtronic | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DEXCOM G6 TRANSMITTER$322
- FREESTYLE LIBRE 3$270
- FreeStyle Libre Pro$125
- Korlym$124
- DEXCOM G7 GSS (161)$122
- FARXIGA$110
How this compares
$3,645 in reported general payments places this provider in the 80th percentile of 263 medical providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 19 | $25,510 |
| OzempicSemaglutide | 16 | $20,108 |
| MounjaroTirzepatide | 14 | $13,157 |
| Repatha SureclickEvolocumab | 11 | $6,879 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $3,450 |
| Celecoxib | 29 | $650 |
| Omeprazole | 33 | $416 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 17 | $404 |
| Pantoprazole Sodium | 22 | $365 |
| Levothyroxine Sodium | 44 | $334 |
| Losartan Potassium | 30 | $261 |
| Rosuvastatin Calcium | 16 | $219 |
| Atorvastatin Calcium | 44 | $218 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $215 |
| Gabapentin | 14 | $209 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $224 | $25,51019 claims |
| Novo NordiskOzempic | $80 | $20,10816 claims |
| Lilly USA, LLCMounjaro | $157 | $13,15714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 263 medical providers in Utah.
Other medical in Salt Lake City
- Elisa WilcoxSalt Lake City$178K
- Viet leSalt Lake City$42K
- Carmelo DiazSalt Lake City$35K
- Shari CombeSalt Lake City$22K
- Abbie SiebenhaarSalt Lake City$7K
- Gerald KeltySalt Lake City$6K
- Alanna JorgensenSalt Lake City$6K
- Alyssa SmithSalt Lake City$5K
- Michael SwinyerSalt Lake City$5K
- Louise TobeySalt Lake City$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.